Position in IMCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,602,834
+$2,478,578 QoQ
Shares Held
119,497
+268.9% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Derivatives in IMCR
reported options exposure · as of Mar 31, 2024CallValue
$3,035,500
CallShares
46,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,293,152,367 across 364 Biotechnology names. IMCR ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in IMCR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,602,834 | 119,497 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,124,256 | 32,390 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,142,634 | 58,977 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,410,719 | 44,956 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $927,395 | 31,257 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,063,150 | 36,039 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $7,045,995 | 226,341 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,056,335 | 90,184 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,035,500 | 46,700 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $6,292,455 | 96,807 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,325,271 | 48,672 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,908,329 | 75,305 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $373,680 | 7,200 | Call | Defined | 2024-05-15 | |
| 2023-06-30 | $5,278,038 | 88,026 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,026,051 | 40,980 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,473,585 | 43,343 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||